logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Toni K. Choueiri

Dana-Farber Cancer Institute

149H-index
2.5KPaper Count
12.6WCitation Count
Published Papers 692
Publication Date
logo
11 Long-Term Follow-Up from the OMNIVORE Trial: Response-Adaptive Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma (NCT03652142)
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errMichael Serzan; Wanling Xie; Bradley Mcgregor; David Braun; Xiao Wei; Christos Kyriakopoulos; Yousef Zakharia; Benjamin Maughan; Tracy Rose; Walter Stadler; David McDermott; Toni Choueiri; Rana McKay
errShare
errSave
72 Time-of-day of Immune Checkpoint Inhibitor Infusion and Overall Survival in Renal Cell Carcinoma: A Real-World Cohort Analysis
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errPablo Barrios; Mustafa Saleh; Liliana Ascione; Ali Hajj Ali; Tarek Baroud; Marc Eid; Razane El Hajj Chehade; Sara El Sarout; Jad El Masri; Elio Ibrahim; Marc Machaalani; Gaelle Nafeh; Rashad Nawfal; Patrick A Ott; F Stephen Hodi; Kenneth L Kehl; Wanling Xie; Bradley McGregor; Alexander Gusev; Toni K Choueiri
errShare
errSave
54 Primary Progressive Disease and Outcomes with First-Line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma: A Real-World IMDC Analysis
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errElio Ibrahim; Wanling Xie; Razane El Hajj Chehade; Neeraj Agarwal; Liliana Ascione; Parker Baumgarten; Tarek Baroud; Pablo Barios; Benoit Beuselinck; Christian Camil; Sarah El Sarout; Marc eid; Jad El Masri; Ali Hajj Ali; Christian Kollmannsberger; Suzanna Lee; Jae Lyun Lee; Marc Machaalani; Gaelle Nafeh; Rashad Nawfal; Heber Reyes Garcia; Mustafa Saleh; Connor Wells; Lori Wood; Jessica Voce; Sylvan Baca; Daniel Heng; Toni Choueiri; Rana McKay
errShare
errSave
76 Defining Young-Onset Renal Cell Carcinoma (YORCC): a Registry-Based Analysis of Incidence Trends
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errWassim Daoud Khatoun; Liliana Ascione; Mustafa Saleh; Pablo Barrios; Fouad Attieh; Eddy Saad; Rashad Nawfal; Marc Eid; Gaelle Nafeh; Sara El Sarout; Razane El Hajj Chehade; Elio Ibrahim; Marc Machaalani; Jad El Masri; Ali Hajj Ali; Tarek Baroud; Alexander Gusev; Kimmie Ng; Ryan Collins; Toni Choueiri
errShare
errSave
70 Lymphocyte Hsp70 is a Novel Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errEthan Burns; Soki Kashima; Rishabh Rout; Miya Hugaboom; Mustafa Saleh; Zhaochen Ye; Nicholas Schindler; Anasuya Dighe; Maxine Sun; Gwo-Shu Mary Lee; Wenxin Xu; Michael Atkins; Sabina Signoretti; Bradley McGregor; Rana McKay; Toni Choueiri; David Braun
errShare
errSave
49 Effect of Co-Morbidity Burden on the Efficacy and Tolerability of Belzutifan in Patients with Metastatic Renal Cell Carcinoma
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errAli Hajj Ali; Liliana Ascione; Rashad Nawfal; Wassim Daoud Khatoun; Pablo Barrios; Marc Machaalani; Razane El Hajj Chehade; Jad El Masri; Mustafa Saleh; Marc Eid; Elio Ibrahim; Gaelle Nafeh; Tarek Baroud; Sara El Sarout; Bradley A McGregor; Toni K Choueiri
errShare
errSave
75 Transcriptional Correlates of ARNT Expression and its Impact on Survival Outcomes in Clear-Cell Renal Cell Carcinoma (ccRCC)
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errWassim Daoud Khatoun; Ali Hajj Ali; Eddy Saad; Mustafa Saleh; Jad El Masri; Pablo Barrios; Chris Labaki; Harry Kane; Kevin Meli; Renee Maria Saliby; Ro Malik; Sabina Signoretti; David McDermott; Rana McKay; Eli Van Allen; David Braun; Toni Choueiri
errShare
errSave
51 Discovery of Exhausted CD8+ T-cell States Associated with Clinical Outcomes in Renal Cell Carcinoma
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errZhaochen Ye; Soki Kashima; Rishabh Rout; Colin Laughlin; Nicholas Schindler; Ro Malik; Maxine Sun; Mustafa Saleh; Gwo-Shu Mary Lee; Wenxin Xu; Sabina Signoretti; Michael Hurwitz; Adebowale Adeniran; Peter Humphrey; Patrick Kenney; Bradley McGregor; Rana Mckay; Toni Choueiri; David Braun
errShare
errSave
61 Differential Pattern of Disease Recurrence in Resected Renal Cell Carcinoma Patients Treated with Adjuvant Pembrolizumab Versus Observation: A Propensity Score-Weighted Analysis
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errLiliana Ascione; Marco Stellato; Alessio Polymeropoulos; Elena Verzoni; Razane El Hajj Chehade; Gaelle Nafeh; Bohuslav Melichar; Rana R McKay; Francesco Massari; Daniel Y C Heng; Parker Baumgarten; Martin Zarba; Irene Tsung; Wadih Issa; Tian Zhang; Hernan Javier Cutuli; Tom Ferguson; Sebastiano Buti; Maria Baronchelli; Sarah Scagliarini; Toni K Choueiri; Giuseppe Procopio
errShare
errSave
60 Germline Platelet Polygenic Risk Score Predicts Renal Cell Carcinoma Survival via Sustained Thrombocytosis
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errMustafa Saleh; Eddy Saad; Pablo Barrios; Wassim Daoud Khatoun; Jad El Masri; Marc Machaalani; Liliana Ascione; Clara Steiner; Rashad Nawfal; Razane El Hajj Chehade; Marc Eid; Elio Ibrahim; Gaelle Nafeh; Shaye Carver; Zeyun Lu; Emre Yekeduz; Tarek Baroud; Sara Sarrout; Ali Hajj Ali; Sylvan Baca; Alexander Gusev; Toni Choueiri
errShare
errSave
66 Relationship Between Health-related Quality of Life and Efficacy in the Phase 3 LITESPARK-005 Study of Belzutifan versus Everolimus in Previously Treated Advanced Clear Cell Renal Cell Carcinoma
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errPooja Ghatalia; Thomas B Powles; Laurence Albiges; Katriina Peltola; Guillermo de Velasco; Mauricio Burotto; Cristina Suarez; Elaine T Lam; Roberto Iacovelli; Mahmut Gumus; Elena Verzoni; Christian Kollmannsberger; Walter M Stadler; Reshma Shinde; Todd L Saretsky; Li He; Donna Vickery; Toni K Choueiri; Brian Rini
errShare
errSave
57 Final Analysis of the TiNivo-2 Phase 3 Trial: Long-term Outcome of Tivozanib (Tivo) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errRobert Motzer; Bradley McGregor; Laurence Albiges; Javier Molina-Cerrillo; Phillipe Barthelemy; Maria Bourlon; Benjamin Garmezy; Sheik Emambux; Arnab Basu; Raffaele Ratta; Pedro Barata; Jeffrey Yorio; Helen Moon; Alex Chehrazi-Raffle; Roberto Iacovelli; Ralph Hauke; Rana McKay; Kathryn Beckermann; Moshe Ornstein; Toni Choueiri
errShare
errSave
19 Dissecting ARNT Expression Patterns in RCC and Association with Outcomes
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errYu-Wei Chen; Shayan Nazari; Andrew Elliott; Ninad Kulkarni; Liliana Ascione; Ali Hajj Ali; Pedro Barata; Brent Rose; Aditya Bagrodia; Neeraj Aggrawal; Sumanta Pal; Toni Choueiri; Rana McKay
errShare
errSave
88 PEAK-1 (NCT07011719): A Randomized, Double-Blind, Active-Control Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errToni K Choueiri; Sumanta Pal; Rana R McKay; Cristina Suarez; John B A G Haanen; Deepti Warad; Chris Negro; Melissa Eiseen; Paul Foster; Tom Powles
errShare
errSave
85 Phase 3 LITESPARK-033 (NCT07227402) Study of Belzutifan Plus Zanzalintinib Versus Cabozantinib for Recurrent Clear Cell Renal Cell Carcinoma During or After Adjuvant Anti–PD-(L)1 Therapy
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errToni K Choueiri; Thomas Powles; Martin H Voss; Marc-Oliver Grimm; Kelly N Fitzgerald; Brian Simmons; Jerry Cornell; Joseph E Burgents; Priyanka Chablani; Cristina Suarez
errShare
errSave
4 Baseline and Early On-Treatment Plasma Kidney Injury Molecule-1 (KIM-1) Levels are Associated with Outcomes in Advanced Renal Cell Carcinoma (aRCC)
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errWenxin Xu; Habib Hamidi; Robert J Motzer; Thomas Powles; Laurence Albiges; Marc Machaalani; Svetlana Andrianova; Saurabh Gupta; Venu Valmeekam; Toni K Choueiri; Bradley A McGregor; Andrew Simmons
errShare
errSave
1 Pembrolizumab Plus Belzutifan Versus Pembrolizumab Plus Placebo as Adjuvant Therapy for Renal Cell Carcinoma: Patient-Reported Outcomes in LITESPARK-022
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errThomas B Powles; Toni K Choueiri; Jose A Karam; Cristina Suarez; Wesley Yip; Rana R McKay; Thomas Ferguson; Pooja Ghatalia; Christian Caglevic; Jad Chahoud; Roberto Iacovelli; Hans Hammers; Carlos Rojas; Rui Kang; Todd L Saretsky; Manish Sharma; Joseph E Burgents; Robert J Motzer
errShare
errSave
86 SPARCC: A Single Arm Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma (NCT07123090)
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errPrateek Khanna; Bradley McGregor; Srinivas Viswanathan; Michael Serzan; Wenxin (Vincent) Xu; Bicky Thapa; Wanling Xie; Toni Choueiri; Stephanie Berg
errShare
errSave
74 HIF2α Downregulation and Clinical Outcomes in Patients with Clear Cell Renal Cell Carcinoma with and without Sarcomatoid Differentiation
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errRashad Nawfal; Elio Ibrahim; Karl Semaan; Ali Hajj Ali; Talal El Zarif; Razane El Hajj Chehade; Gunsagar Gulati; Damien Vasseur; Garyoung Gary Lee; Ze Zhang; Gwo Shu Mary Lee; Ji-Heui Seo; Bradley McGregor; Matthew Freedman; Sylvan Baca; Toni Choueiri
errShare
errSave
6 Antitumor Activity of 177Lu-PSMA-617 in PSMA-Positive Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): Results from a Phase 2 Trial (LASER)
errOncologist
IF4.2
err2026-09-02
err0
errOAAI
errPraful Ravi; Wanling Xie; Shir Hazut Krauthammer; Liliana Ascione; Luke Arsenault; Liliane Kabarame; Nicole LaBrecque; Hina Shah; Stephanie Berg; Atish Choudhury; Bradley McGregor; Michael Serzan; Wenxin Xu; Srinivas Viswanathan; Xiao Wei; Toni Choueiri; Heather Jacene
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
G
Gordon B. Mills
H-index: 231 · Papers: 3.5K
M
Matthew Meyerson
H-index: 223 · Papers: 1.9K
C
Charles M. Perou
H-index: 193 · Papers: 2.0K
A
Anil K. Sood
H-index: 174 · Papers: 3.3K
J
John N. Weinstein
H-index: 163 · Papers: 987
View more